ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $192,691,423 | -22.7% | 5,405,089 | 0.0% | 4.07% | -14.3% |
| Q2 2023 | $249,336,756 | +45.6% | 5,405,089 | +26.6% | 4.75% | +33.1% |
| Q1 2023 | $171,266,940 | -6.8% | 4,270,996 | +7.7% | 3.57% | -5.0% |
| Q4 2022 | $183,787,172 | +88.1% | 3,966,915 | +68.1% | 3.75% | +66.5% |
| Q3 2022 | $97,727,000 | +19.3% | 2,359,996 | +71.9% | 2.25% | +6.4% |
| Q2 2022 | $81,930,000 | -17.8% | 1,373,284 | 0.0% | 2.12% | +2.6% |
| Q1 2022 | $99,728,000 | -13.6% | 1,373,284 | 0.0% | 2.06% | +22.4% |
| Q4 2021 | $115,479,000 | – | 1,373,284 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |